Inhibition of cellular differentiation by the SCL/tal oncoprotein: transcriptional repression by an Id-like mechanism.

Abstract:

:In cases of T-cell acute lymphoblastic leukemia (T-ALL), the basic helix-loop-helix (bHLH) oncogene SCL/tal undergoes frequent rearrangements activating ectopic expression. Despite the compelling epidemiological association of SCL/tal expression with T-ALL, no specific transforming function has been attributable to the protein product. However, investigators have recently demonstrated that forced overexpression of SCL/tal can block monocytic differentiation of M1 murine myeloid leukemia cells. Thus, inappropriate expression of wild-type SCL/tal protein may in part account for the maturation arrest phenotype observed in T-ALL cells. In this study, ectopic expression of the SCL/tal gene blocked the differentiation of C2C12 muscle precursor cells. Characterization of the mechanism of differentiation blockade showed that the SCL/tal protein repressed transcriptional activation by the myogenic bHLH factor MyoD. Protein interaction analysis showed that SCL/tal and MyoD compete for common partners (E bHLH proteins) but do not directly bind one other. A model is thus proposed in which ectopic SCL/tal protein, by its ability to titrate out E proteins, prevents the formation of bHLH complexes that drive cellular differentiation: the "Id-like" mechanism.

journal_name

Blood

journal_title

Blood

authors

Goldfarb AN,Lewandowska K

subject

Has Abstract

pub_date

1995-01-15 00:00:00

pages

465-71

issue

2

eissn

0006-4971

issn

1528-0020

journal_volume

85

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Contact activation triggers stimulation of the monocyte 5-lipoxygenase pathway via plasmin.

    abstract::The purpose of this study was to characterize the stimulus that activates the 5-lipoxygenase pathway in human peripheral monocytes (PM) during the process of contact activation. Incubation of PM, but not of polymorphonuclear leukocytes (PMN), in contact-activated, recalcified plasma induced a time-dependent release of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Weide I,Römisch J,Simmet T

    更新日期:1994-04-01 00:00:00

  • Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model.

    abstract::Autoimmune hemolytic anemia (AIHA) is a disease in which autoantibodies against red blood cells (RBCs) lead to their premature destruction. Most clinically significant autoantibodies are of the immunoglobulin G (IgG) type, which leads primarily to the uptake and destruction of RBCs by splenic and hepatic macrophages. ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2001-11-0061

    authors: Jordan MB,van Rooijen N,Izui S,Kappler J,Marrack P

    更新日期:2003-01-15 00:00:00

  • The molecular species composition of phosphatidylcholine affects cellular properties in normal and sickle erythrocytes.

    abstract::The phosphatidylcholine specific transfer protein (PCTP) from bovine liver was used to retailor the molecular species composition of phosphatidylcholine (PC) in the membrane of normal (AA) and sickleable (SS) human erythrocytes. Changes in molecular species composition of PC altered morphology as well as cellular defo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kuypers FA,Chiu D,Mohandas N,Roelofsen B,Op den Kamp JA,Lubin B

    更新日期:1987-10-01 00:00:00

  • Establishment and characterization of a new human leukemia cell line derived from M4E0.

    abstract::A new human leukemia cell line, designated as ME-1, was established from the peripheral blood leukemia cells of a patient with acute myelomonocytic leukemia with eosinophilia (M4E0). This cell line has the characteristic chromosome abnormality of M4E0, inv(16) (p13q22). When cultured in RPMI 1640 medium containing 10%...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yanagisawa K,Horiuchi T,Fujita S

    更新日期:1991-07-15 00:00:00

  • Approach to the treatment of multiple myeloma: a clash of philosophies.

    abstract::In this Perspective, we summarize some of the most contentious issues surrounding diagnosis and treatment of myeloma. We outline how a fundamental clash of philosophies, cure versus control, may be at the heart of many of the controversies. From the very definition of the disease to risk stratification to the validity...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-297853

    authors: Rajkumar SV,Gahrton G,Bergsagel PL

    更新日期:2011-09-22 00:00:00

  • Inhibitory effect of granulocyte-macrophage colony-stimulating factor therapy on the generation of natural killer cells.

    abstract::We investigated the effects of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF) therapy on the natural killer (NK) cell lineage in patients with aplastic anemia and myelodysplastic syndrome. Selected bone marrow (BM) cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Shibuya A,Taguchi K,Kojima H,Abe T

    更新日期:1991-12-15 00:00:00

  • Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice.

    abstract::Oncostatin M (OSM) and leukemia inhibitory factor (LIF) are members of the interleukin-6 (IL-6) subfamily of cytokines that use a common signal transducer gp130. Human OSM (hOSM) and LIF share a functional high-affinity receptor that is composed of gp130 and LIF receptor beta subunit (LIFRbeta). A second high-affinity...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ichihara M,Hara T,Kim H,Murate T,Miyajima A

    更新日期:1997-07-01 00:00:00

  • Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium.

    abstract::Cerebral malaria is a severe multifactorial condition associated with the interaction of high numbers of infected erythrocytes to human brain endothelium without invasion into the brain. The result is coma and seizures with death in more than 20% of cases. Because the brain endothelium is at the interface of these pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-06-226415

    authors: Tripathi AK,Sha W,Shulaev V,Stins MF,Sullivan DJ Jr

    更新日期:2009-11-05 00:00:00

  • Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

    abstract::The Children's Cancer Group (CCG) and the Pediatric Oncology Group (POG) joined to form the Children's Oncology Group (COG) in 2000. This merger allowed analysis of clinical, biologic, and early response data predictive of event-free survival (EFS) in acute lymphoblastic leukemia (ALL) to develop a new classification ...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2006-01-024729

    authors: Schultz KR,Pullen DJ,Sather HN,Shuster JJ,Devidas M,Borowitz MJ,Carroll AJ,Heerema NA,Rubnitz JE,Loh ML,Raetz EA,Winick NJ,Hunger SP,Carroll WL,Gaynon PS,Camitta BM

    更新日期:2007-02-01 00:00:00

  • Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity.

    abstract::We investigated whether atorvastatin (AT) was capable of protecting animals from acute graft-versus-host disease (aGVHD) across major histocompatibility complex (MHC) mismatch barriers. AT treatment of the donor induced a Th-2 cytokine profile in the adoptively transferred T cells and reduced their in vivo expansion, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-08-106005

    authors: Zeiser R,Youssef S,Baker J,Kambham N,Steinman L,Negrin RS

    更新日期:2007-12-15 00:00:00

  • Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature.

    abstract::Adenovirus-transduced CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (CD34-TRAIL+ cells) exert potent antitumor activity. To further investigate the mechanism(s) of action of CD34-TRAIL+ cells, we analyzed their homing properties as well as antitumor and antivascular effe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-08-239632

    authors: Lavazza C,Carlo-Stella C,Giacomini A,Cleris L,Righi M,Sia D,Di Nicola M,Magni M,Longoni P,Milanesi M,Francolini M,Gloghini A,Carbone A,Formelli F,Gianni AM

    更新日期:2010-03-18 00:00:00

  • Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.

    abstract::The clinical and prognostic relevance of many recently identified driver gene mutations in adult acute myeloid leukemia (AML) is poorly defined. We sequenced the coding regions or hotspot areas of 68 recurrently mutated genes in a cohort of 664 patients aged 18 to 86 years treated on 2 phase 3 trials of the German AML...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2016-01-693879

    authors: Metzeler KH,Herold T,Rothenberg-Thurley M,Amler S,Sauerland MC,Görlich D,Schneider S,Konstandin NP,Dufour A,Bräundl K,Ksienzyk B,Zellmeier E,Hartmann L,Greif PA,Fiegl M,Subklewe M,Bohlander SK,Krug U,Faldum A,Berdel

    更新日期:2016-08-04 00:00:00

  • Exposure of R169 controls protein C activation and autoactivation.

    abstract::Protein C is activated by thrombin with a value of k(cat)/K(m) = 0.11mM(-1)s(-1) that increases 1700-fold in the presence of the cofactor thrombomodulin. The molecular origin of this effect triggering an important feedback loop in the coagulation cascade remains elusive. Acidic residues in the activation domain of pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-03-415323

    authors: Pozzi N,Barranco-Medina S,Chen Z,Di Cera E

    更新日期:2012-07-19 00:00:00

  • Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.

    abstract::Protein tyrosine phosphorylation plays a crucial role in signaling from the receptor for erythropoietin (Epo), although the Epo receptor (EpoR) lacks the tyrosine kinase domain. We have previously shown that the Jak2 tyrosine kinase couples with the EpoR to transduce a growth signal. In the present study, we demonstra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chin H,Arai A,Wakao H,Kamiyama R,Miyasaka N,Miura O

    更新日期:1998-05-15 00:00:00

  • Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia.

    abstract::The prevalence, the prognostic effect, and interaction with other molecular markers of DNMT3A mutations was studied in 415 patients with acute myeloid leukemia (AML) younger than 60 years. We show mutations in DNMT3A in 96 of 415 patients with newly diagnosed AML (23.1%). Univariate Cox regression analysis showed that...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-07-367961

    authors: Ribeiro AF,Pratcorona M,Erpelinck-Verschueren C,Rockova V,Sanders M,Abbas S,Figueroa ME,Zeilemaker A,Melnick A,Löwenberg B,Valk PJ,Delwel R

    更新日期:2012-06-14 00:00:00

  • Thyroid hormone regulates hematopoiesis via the TR-KLF9 axis.

    abstract::Congenital hypothyroidism (CH) is one of the most prevalent endocrine diseases, for which the underlying mechanisms remain unknown; it is often accompanied by anemia and immunodeficiency in patients. Here, we created a severe CH model together with anemia and T lymphopenia to mimic the clinical features of hypothyroid...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-05-783043

    authors: Zhang Y,Xue Y,Cao C,Huang J,Hong Q,Hai T,Jia Q,Wang X,Qin G,Yao J,Wang X,Zheng Q,Zhang R,Li Y,Luo A,Zhang N,Shi G,Wang Y,Ying H,Liu Z,Wang H,Meng A,Zhou Q,Wei H,Liu F,Zhao J

    更新日期:2017-11-16 00:00:00

  • Loxosceles intermedia spider envenomation induces activation of an endogenous metalloproteinase, resulting in cleavage of glycophorins from the erythrocyte surface and facilitating complement-mediated lysis.

    abstract::Loxosceles is the most venomous spider in Brazil, and envenomation causes dermonecrosis and complement (C)-dependent intravascular hemolysis. The authors studied the mechanism of induction of C-induced hemolysis. Purified Loxosceles toxins rendered human erythrocytes susceptible to lysis by human C but did not have an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tambourgi DV,Morgan BP,de Andrade RM,Magnoli FC,van Den Berg CW

    更新日期:2000-01-15 00:00:00

  • Prion protein expression in human leukocyte differentiation.

    abstract::The cellular isoform of the prion protein (PrPC) is a small glycoprotein attached to the outer leaflet of the plasma membrane by a glycosylphosphatidylinositol anchor. This molecule is involved in the pathogenesis of prion diseases in both humans and animals. We have characterized the expression patterns of PrPC durin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dodelet VC,Cashman NR

    更新日期:1998-03-01 00:00:00

  • RUNX1 positively regulates a cell adhesion and migration program in murine hemogenic endothelium prior to blood emergence.

    abstract::During ontogeny, the transcription factor RUNX1 governs the emergence of definitive hematopoietic cells from specialized endothelial cells called hemogenic endothelium (HE). The ultimate consequence of this endothelial-to-hematopoietic transition is the concomitant activation of the hematopoietic program and downregul...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-04-572958

    authors: Lie-A-Ling M,Marinopoulou E,Li Y,Patel R,Stefanska M,Bonifer C,Miller C,Kouskoff V,Lacaud G

    更新日期:2014-09-11 00:00:00

  • Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells.

    abstract::Clinical trials have been started with the aim of inducing tumor immunity by blocking the immunosuppressive action of indoleamine-2,3-dioxygenase (IDO) with the IDO2-inhibitor dextro-1-methyl-tryptophan (D-1MT). Here we show that human dendritic cells (DCs) express both IDO-1 and IDO-2, but that only IDO1 mediates try...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-10-116111

    authors: Lob S,Konigsrainer A,Schafer R,Rammensee HG,Opelz G,Terness P

    更新日期:2008-02-15 00:00:00

  • Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease.

    abstract::Sickle cell disease is a common hemolytic disorder with a broad range of complications, including vaso-occlusive episodes, acute chest syndrome (ACS), pain, and stroke. Heme oxygenase-1 (gene HMOX1; protein HO-1) is the inducible, rate-limiting enzyme in the catabolism of heme and might attenuate the severity of outco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-361642

    authors: Bean CJ,Boulet SL,Ellingsen D,Pyle ME,Barron-Casella EA,Casella JF,Payne AB,Driggers J,Trau HA,Yang G,Jones K,Ofori-Acquah SF,Hooper WC,DeBaun MR

    更新日期:2012-11-01 00:00:00

  • The interaction of platelets with aortic subendothelium: inhibition of adhesion and secretion by prostaglandin I2.

    abstract::We have studied the effect of prostaglandin I2 on platelet turnover, attachment to the subendothelium, and secretion following balloon deendothelialization of the rabbit aorta. Survival of 51Cr-labeled platelets in the balloon-injured animals remained normal. Thirty minutes after injury, there were 4.52 X 10(6) platel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Adelman B,Stemerman MB,Mennell D,Handin RI

    更新日期:1981-08-01 00:00:00

  • Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia.

    abstract::Patients with relapsed chronic lymphocytic leukemia (CLL) and high-risk features, such as fludarabine refractoriness, complex karyotype, or abnormalities of chromosome 17p, experience poor outcomes after standard fludaradine-based regimens. Alemtuzumab is a chimeric CD52 monoclonal antibody with activity in CLL patien...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-341032

    authors: Badoux XC,Keating MJ,Wang X,O'Brien SM,Ferrajoli A,Faderl S,Burger J,Koller C,Lerner S,Kantarjian H,Wierda WG

    更新日期:2011-08-25 00:00:00

  • Antibody response to intravenous immunization following splenic tissue autotransplantation in Sprague-Dawley rats.

    abstract::The response to intravenous challenge with sheep erythrocytes was determined in Sprague-Dawley rats following autotransplantation of splenic tissue into the subcutaneous tissue, peritoneal cavity, or a surgically created omental pouch. There was a marked rise in heterophil antibody titer following intravenous challeng...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schwartz AD,Dadash-Zadeh M,Goldstein R,Luck S,Conway JJ

    更新日期:1977-05-01 00:00:00

  • Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation.

    abstract::Marrow cells of myeloid lineage from 115 patients with myelodysplastic syndrome (MDS) were characterized by multidimensional flow cytometry and compared with findings in 104 patients with various disorders and 25 healthy donors. Based on phenotypic and scatter characteristics, a flow cytometric scoring system (FCSS) w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-09-2768

    authors: Wells DA,Benesch M,Loken MR,Vallejo C,Myerson D,Leisenring WM,Deeg HJ

    更新日期:2003-07-01 00:00:00

  • "You break it, you fix it.".

    abstract::Nonrandom chromosomal translocations are considered to be causal events leading to leukemic transformation. However, the mechanism(s) that cause these translocations are poorly understood. Libura and colleagues report exciting new findings on the mechanism(s) that lead to chromosomal translocation. ...

    journal_title:Blood

    pub_type: 评论,杂志文章,评审

    doi:10.1182/blood-2004-12-4760

    authors: Aplan PD

    更新日期:2005-03-01 00:00:00

  • Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients.

    abstract::Liver injury is a frequent, serious complication of allogeneic hematopoietic cell transplantation (HCT) following myeloablative preparative regimens. We sought to determine the frequency and severity of hepatic injury after nonmyeloablative conditioning and its relationship to outcomes. One hundred ninety-three consec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-04-1311

    authors: Hogan WJ,Maris M,Storer B,Sandmaier BM,Maloney DG,Schoch HG,Woolfrey AE,Shulman HM,Storb R,McDonald GB

    更新日期:2004-01-01 00:00:00

  • CD177 modulates human neutrophil migration through activation-mediated integrin and chemoreceptor regulation.

    abstract::CD177 is a glycosylphosphatidylinositol (GPI)-anchored protein expressed by a variable proportion of human neutrophils that mediates surface expression of the antineutrophil cytoplasmic antibody antigen proteinase 3. CD177 associates with β2 integrins and recognizes platelet endothelial cell adhesion molecule 1 (PECAM...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-03-768507

    authors: Bai M,Grieshaber-Bouyer R,Wang J,Schmider AB,Wilson ZS,Zeng L,Halyabar O,Godin MD,Nguyen HN,Levescot A,Cunin P,Lefort CT,Soberman RJ,Nigrovic PA

    更新日期:2017-11-09 00:00:00

  • Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN.

    abstract::Hypomethylating agents (HMAs) improve survival in patients with higher-risk myelodysplastic syndromes (MDS) but are less well-studied in lower-risk disease. We compared the safety and efficacy of low-dose decitabine vs low-dose azacitidine in this group of patients. Adults with low- or intermediate 1-risk MDS or MDS/m...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2017-06-788497

    authors: Jabbour E,Short NJ,Montalban-Bravo G,Huang X,Bueso-Ramos C,Qiao W,Yang H,Zhao C,Kadia T,Borthakur G,Pemmaraju N,Sasaki K,Estrov Z,Cortes J,Ravandi F,Alvarado Y,Komrokji R,Sekeres MA,Steensma DP,DeZern A,Roboz G,

    更新日期:2017-09-28 00:00:00

  • Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells.

    abstract::Bortezomib (PS-341), a selective inhibitor of proteasomes, induces apoptosis in multiple myeloma (MM) cells; however, prolonged drug exposure may result in cumulative toxicity and the development of chemoresistance. Here we show that combining PK-11195 (PK), an antagonist to mitochondrial peripheral benzodiazepine rec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-02-0547

    authors: Chauhan D,Li G,Podar K,Hideshima T,Mitsiades C,Schlossman R,Munshi N,Richardson P,Cotter FE,Anderson KC

    更新日期:2004-10-15 00:00:00